✦ LIBER ✦
A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients
✍ Scribed by Simeon Metallidis; Panagiotis Kollaras; Theodoros Giannakakis; Basilis Seitanidis; Theodoros Kordosis; John Nikolaidis; Apostolos Hatzitolios; Pavlos Nikolaidis
- Book ID
- 116431952
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 149 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0953-6205
No coin nor oath required. For personal study only.